Olson William C 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Apr 8, 2013
Insider Transaction Report
Form 4
Olson William C
VP, Research & Development
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2013-04-04$5.03/sh+60,000$301,800→ 60,000 totalExercise: $5.03Exp: 2023-04-04→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The stock options become exercisable in three equal annual installments, commencing one year from the grant date.